International Clinical Trial: Efficacy and safety of Serplulimab combined with platinum-based chemotherapy and H1 receptor antagonist (desloratadine) in the First-line Treatment for locally advanced or metastatic non-small cell lung cancer:a prospective randomized controlled study

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125150) titled 'Efficacy and safety of Serplulimab combined with platinum-based chemotherapy and H1 receptor antagonist (desloratadine) in the First-line Treatment for locally advanced or metastatic non-small cell lung cancer:a prospective randomized controlled study' on May 21.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Ningbo Medical Centre Lihuili Hospital

Condition: Non-small cell lung cancer

Intervention: Experimental group:Desloratadine

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-12-03

Target Sample Size: Experimental group:60;Control group:60;

Count...